Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28;9(1):16.
doi: 10.1007/s40203-020-00070-x. eCollection 2021.

An in silico approach to study the interaction of BHA with selected steroid hormone receptors and investigating it's agonistic and antagonistic properties

Subin Balachandran  1 , R N Binitha  2
Affiliations

An in silico approach to study the interaction of BHA with selected steroid hormone receptors and investigating it's agonistic and antagonistic properties

Subin Balachandran et al. In Silico Pharmacol. .

Abstract

Antioxidant food additives were routinely used for increasing the keeping quality of packaged food items. Butylated Hydroxyanisole (BHA) is one of the most widely used synthetic phenolic antioxidants of such kind. Although quantity of antioxidants in packaged eatables and admissible daily intake (ADI) per person per day are limited by laws, the urbanisation and changes in lifestyle has cross these limits. Although studies on BHA has been carried out, there exists a great deal of uncertainty about the exact molecular mechanism of interaction of BHA with various receptors in the body. Since earlier reports suggested BHA plausibly interferes with reproductive system development, we opted docking of critical receptors of endogenous hormones controlling growth and development of reproductive system with BHA. Nuclear receptors of estrogen (ER), androgen (AR) and progesterone (PR) were selected for this purpose. This manuscript describes the comparison of binding pattern of BHA towards AR, ER and PR along with their agonists and antagonist. Lamarckian Genetic Algorithm of AutoDock 4.0 was used for analysing the mode of binding of ligands with the receptors. It is evident form the docking studies that, BHA exhibited similar binding pattern` with antagonists of AR and agonists of ER. But the interaction of BHA with PR was not compatible with either agonists or antagonists. The docking patterns produced could reliably demonstrate the interactions of BHA with selected receptors and also predict its possible agonistic and antagonistic action.

Keywords: Agonists; Antagonists; Antioxidant; BHA; Molecular docking.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interests.

Figures

Fig. 1
Fig. 1
Butylated Hydroxyanisole
Fig. 2
Fig. 2
Docking patterns of different target molecules against Androgen Receptor
Fig. 3
Fig. 3
Docking patterns of different target molecules against Estrogen Receptor
Fig. 3
Fig. 3
Docking patterns of different target molecules against Estrogen Receptor
Fig. 4
Fig. 4
Docking patterns of different target molecules against Progesterone Receptor
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ahirwar R, et al. In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules. Berlin: Nature Publishing Group; 2016. - PMC - PubMed
    1. Anbalagan M, Rowan BG. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer. Mol Cell Endocrinol. 2015;418:264–272. doi: 10.1016/j.mce.2015.01.016. - DOI - PubMed
    1. Carocho M, Morales P, Ferreira ICFR. Trends in food science and technology antioxidants : reviewing the chemistry, food applications, legislation and role as preservatives’, trends in food science and technology. Elsevier. 2018;71:107–120. doi: 10.1016/j.tifs.2017.11.008. - DOI
    1. DeLano WL (2002) The PyMOL molecular graphics system (http://www.pymol.org)
    1. Diamanti-kandarakis E, et al. Endocrine-disrupting chemicals : an endocrine. Endocr Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. - DOI - PMC - PubMed

LinkOut - more resources